Two Sigma Advisers’s Novartis NVS Stock Holding History

Two Sigma Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,803	Closed	-$471K	–	2562
2014 Q2	$471K	Buy	+5,803	New	+$456K	﹤0.01%	1733

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's NVS Position: Q3 2025 in Review

Two Sigma Advisers sold out of Novartis (NVS) in Q3 2025, closing a stake of 4,200 shares — an estimated $508K sold.

Two Sigma Advisers first reported a position in NVS in Q2 2013 and held it in 23 quarters. The position peaked at $258M in Q1 2022. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

Two Sigma Advisers reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
Two Sigma Advisers sold 4,200 Novartis shares in Q3 2025, an estimated $508K.
Two Sigma Advisers first reported a position in Novartis in Q2 2013 and held it in 23 quarters.
Two Sigma Advisers's Novartis position peaked at $258M in Q1 2022.
1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.